Stephen L. Rose, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Rose is the Director of the UW Gynecologic Oncology program, and is certified by the American Board of Obstetrics and Gynecology in both General Obstetrics and Gynecology as well as Gynecologic Oncology. He is a Fellow in the American College of Obstetrics and Gynecology and a nationally known expert in quality of life of gynecologic cancer patients and the use of humor in cancer patients. He embraces minimally invasive surgical interventions for gynecologic cancer such as traditional laparoscopy and robotically assisted laparoscopic surgical techniques.
In 2007, Dr. Rose was named a Liz Tilberis Research Scholar from the Ovarian Cancer Research Fund, Inc. for his research on the Notch 1 signaling pathway in ovarian cancer. He has served on the Ovarian Cancer Committee in the Gynecologic Oncology Group since 2010, helping to shape the future of ovarian cancer clinical trials. He also serves on the Education Committee for the Society of Gynecologic Oncology, the Steering Committee for the Wisconsin Cancer Council and the Editorial Board for the journal Gynecologic Oncology Case Reports. Dr. Rose is also the program director of the University of Wisconsin Fellowship in Gynecologic Oncology. He was nominated twice for a UW Health "Rising Star" award.
UW Health Clinics
Regional Specialty Clinics
UW School of Medicine and Public Health
|Department of Obstetrics and Gynecology|
Professional Certifications and Education
Obstetrics & Gynecology
University of Iowa Hospital and Clinics, Iowa City, IA
St. Vincent Hospital, Indianapolis, IN
Indiana University, Indianapolis, IN
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Turner TB Dilley SE Smith HJ Huh WK Modesitt SC Rose SL Rice LW Fowler JM Straughn JM Jr .
The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis. Gynecol Oncol. 2017 Jun 24;
[PubMed ID: 28655413]
Jennings AJ Spencer RJ Hanks L Barroilhet L Kushner D Rose S Rice L Al-Niaimi A .
The Feasibility and Safety of Adopting Single-Incision Laparoscopic Surgery into Gynecologic Oncology Practice. J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):358-63
[PubMed ID: 26561374]
Honerlaw KR Rumble ME Rose SL Coe CL Costanzo ES .
Biopsychosocial predictors of pain among women recovering from surgery for endometrial cancer. Gynecol Oncol. 2016 Feb;140(2):301-6
[PubMed ID: 26363211]
Rumble ME Rose SL White KH Moore AH Gehrman P Benca RM Costanzo ES .
Circadian actigraphic rest-activity rhythms following surgery for endometrial cancer: A prospective, longitudinal study. Gynecol Oncol. 2015 Jun;137(3):448-55
[PubMed ID: 25906914]
Uppal S Rose SL .
Reply: To PMID 24949539. Am J Obstet Gynecol. 2015 May;212(5):688
[PubMed ID: 25530594]
Uppal S Igwe E Rice LW Spencer RJ Rose SL .
Frailty index predicts severe complications in gynecologic oncology patients. Gynecol Oncol. 2015 Apr;137(1):98-101
[PubMed ID: 25602715]
Cleeland CS Rose SL .
Symptom management of gynecologic cancers: refocusing on the forest. Gynecol Oncol. 2015 Mar;136(3):413-4
[PubMed ID: 25752571]
Spencer RJ Hayes KD Rose S Zhao Q Rathouz PJ Rice LW Al-Niaimi AN .
Risk factors for early-occurring and late-occurring incisional hernias after primary laparotomy for ovarian cancer. Obstet Gynecol. 2015 Feb;125(2):407-13
[PubMed ID: 25568995]
Al-Niaimi AN Ahmed M Burish N Chackmakchy SA Seo S Rose S Hartenbach E Kushner DM Safdar N Rice L Connor J .
Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients. Gynecol Oncol. 2015 Jan;136(1):71-6
[PubMed ID: 25263249]
Igwe E Hernandez E Rose S Uppal S .
Resident participation in laparoscopic hysterectomy: impact of trainee involvement on operative times and surgical outcomes. Am J Obstet Gynecol. 2014 Nov;211(5):484.e1-7
[PubMed ID: 24949539]
Dunn EF Geye H Platta CS Gondi V Rose S Bradley KA Anderson BM .
Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer. Gynecol Oncol. 2014 Jun;133(3):494-8
[PubMed ID: 24657301]
Uppal S Al-Niaimi A Rice LW Rose SL Kushner DM Spencer RJ Hartenbach E .
Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. Gynecol Oncol. 2013 Nov;131(2):416-22
[PubMed ID: 23962700]
Rose SL Spencer RJ Rausch MM .
The use of humor in patients with recurrent ovarian cancer: a phenomenological study. Int J Gynecol Cancer. 2013 May;23(4):775-9
[PubMed ID: 23552803]
Lin JE Seo S Kushner DM Rose SL .
The role of appendectomy for mucinous ovarian neoplasms. Am J Obstet Gynecol. 2013 Jan;208(1):46.e1-4
[PubMed ID: 23117124]
Uppal S Hernandez E Dutta M Dandolu V Rose S Hartenbach E .
Prolonged postoperative venous thrombo-embolism prophylaxis is cost-effective in advanced ovarian cancer patients. Gynecol Oncol. 2012 Dec;127(3):631-7
[PubMed ID: 22940486]
Baggott CD Einstein MH Miranpuri A Rose SL Kuo JS .
What is the optimal venous thromboembolism prophylaxis for gynecological oncology patients with CNS metastases? Gynecol Oncol. 2011 Nov;123(2):409-10
[PubMed ID: 21807402]
Drenzek JG Seiler NL Jaskula-Sztul R Rausch MM Rose SL .
Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines. Gynecol Oncol. 2011 Aug;122(2):396-401
[PubMed ID: 21616523]
Rose SL .
Where once there was color. Obstet Gynecol. 2011 Jan;117(1):143-4
[PubMed ID: 21173656]
Rose SL Kunnimalaiyaan M Drenzek J Seiler N .
Notch 1 signaling is active in ovarian cancer. Gynecol Oncol. 2010 Apr;117(1):130-3
[PubMed ID: 20060575]
Bradford L Swartz K Rose S .
Primary angiosarcoma of the ovary complicated by hemoperitoneum: a case report and review of the literature. Arch Gynecol Obstet. 2010 Jan;281(1):145-50
[PubMed ID: 19396453]